Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures - No Study Results Posted

Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures (ELEVATE)

This study has been suspended.

( IDMC Recommendation )

Study NCT00678587 Information provided by GlaxoSmithKline

First Received: May 13, 2008 Last Updated: November 12, 2009 History of Changes

No Study Results Posted for this Study

About Study Results Reporting

Study Status:	This study has been suspended.
Estimated Study Completion Date:	August 2010
Estimated Primary Completion Date:	August 2010 (Final data collection date for primary outcome measure)